INDIANAPOLIS -- Eli Lilly and Co. (LLY) on Wednesday reported a fourth-quarter loss of ... while the Standard & Poor's 500 index has risen almost 6 percent. The stock has climbed 15 percent in the last 12 months.
Oct 2 (Reuters) - Eli Lilly And Co :Eli Lilly And Co says Lilly Endowment Inc reports open market sale of 162,557 shares of co's common stock at average of $85.1/shr‍ on Sept 29 - sec filing.Eli Lilly And Co says Lilly Endowment Inc reports …
Egalet (NASDAQ: EGLT) announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at a public offering price of $11.25 per share. The gross proceeds to Egalet from this offering are expected to be …
Major pharma companies like Pfizer PFE, Merck MRK and Lilly LLY reported fourth quarter results this week. Meanwhile, Teva TEVA was hit by an unfavorable ruling in the Copaxone patent infringement lawsuit. The NYSE ARCA …
The post Insider Trading Activity Eli Lilly and Co (NYSE:LLY) – Major Shareholder Sold 210,000 shares of Stock
Some studies link the drug Prozac, first patented by Eli Lilly (NYSE: LLY) with behavioral and emotional changes ... Now, one boy is dead and another is in the morgue. Will Eli Lilly's stock take a tumble after the verdict, or will the judge find …
Because Eli Lilly & Co.’s (LLY) breast cancer treatment failed in clinical trials, analysts at Guggenheim cut the stock’s price target and the company’s earnings estimates. However, the analysts still maintain an “Outperform” rating on LLY.
Companies like Pfizer PFE, Merck MRK and Eli Lilly LLY were in the news this week – while Pfizer is mulling strategic options for its Consumer Healthcare business, Merck said that it will not file its CETP inhibitor. Recap of the Week’s …
The stock market is up 17% in the last year and up a whopping 197% since its March 2009 low. Unfortunately, far too many young people haven't participated in this rally, and, unfortunately, this may be detrimental to their futures. …